Sleep Subdomain of the Sinonasal Outcome Test as a Potential Screening Tool for Sleep Apnea in Chronic Rhinosinusitis
The Laryngoscope · 2023
DOI: 10.1002/lary.30730 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2023. Verfasst von Alexander N Duffy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Sleep Apnea Syndromes, Sinusitis, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Approximately 20% of patients with chronic rhinosinusitis (CRS) have comorbid obstructive sleep apnea (OSA). Patients with undiagnosed OSA are at high risk for perioperative complications. The Sinonasal Outcomes Test (SNOT‐22) Questionnaire is commonly administered to CRS patients, whereas OSA screening tools are less routinely employed. This study compared SNOT‐22 sleep subdomain (Sleep‐SNOT) scores among non‐OSA CRS versus OSA‐CRS patients undergoing ESS, and assessed sensitivity, specificity, and diagnostic accuracy of the Sleep‐SNOT for OSA screening.
Methods
Retrospective review of patients that underwent endoscopic sinus surgery (ESS) for CRS from 2012 to 2021. Patients either carried a reported OSA diagnosis and completed the SNOT‐22, or had undocumented OSA status and completed both STOP‐BANG and SNOT‐22. Demographics, questionnaire scores, and OSA status were collected. A receiver operating characteristic (ROC) curve assessed cutoff scores, sensitivity, and specificity of the Sleep‐SNOT for OSA screening.
Results
Of 600 patients reviewed, 109 were included. 41% had comorbid OSA. OSA patients had a higher BMI (32.1 ± 7.7 vs. 28.35 ± 6.7 kg/m 2 ; p = 0.02), Sleep‐SNOT (21.96 ± 12.1 vs. 16.8 ± 11.2; p = 0.021) and STOP‐BANG (3.1 ± 1.44 vs. 2.06 ± 1.27; p = 0.038) scores. A Sleep‐SNOT score of 17.5 had a sensitivity of 68.9%, specificity of 55.7%, and diagnostic accuracy of 63% for OSA detection ( p = 0.022).
Conclusions
Sleep‐SNOT scores are greater for CRS‐OSA patients. The Sleep‐SNOT ROC curve demonstrates a high sensitivity, specificity, and accuracy for OSA screening in CRS patients. A Sleep‐SNOT score of ≥17.5 should prompt further OSA evaluation. The Sleep‐SNOT may be considered as a surrogate OSA screening tool when other validated tools are not employed. Level of Evidence Retrospective chart review, Level 3 Laryngoscope , 133:2029–2034, 2023
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Division of Otolaryngology - Head and Neck Surgery, Lehigh Valley Health Network, Allentown, PA, USA.
- Department of Surgery, University of South Florida, Tampa, FL, USA.
ORCID-Profile: Alexander N Duffy, Chandala Chitguppi, Sean M Parsel, Marc R Rosen
Zitieren
APA
Duffy, A. N., Alapati, R., Chitguppi, C., D'Souza, G., Parsel, S. M., Toskala, E. M., Rosen, M. R., Nyquist, G. G., & Rabinowitz, M. R. (2023). Sleep Subdomain of the Sinonasal Outcome Test as a Potential Screening Tool for Sleep Apnea in Chronic Rhinosinusitis. The Laryngoscope. https://doi.org/10.1002/lary.30730
Vancouver
Duffy AN, Alapati R, Chitguppi C, D'Souza G, Parsel SM, Toskala EM, et al. Sleep Subdomain of the Sinonasal Outcome Test as a Potential Screening Tool for Sleep Apnea in Chronic Rhinosinusitis. The Laryngoscope. 2023. doi:10.1002/lary.30730
BibTeX
@article{Duffy2023,
author = {Duffy, Alexander N and Alapati, Rahul and Chitguppi, Chandala and D'Souza, Glen and Parsel, Sean M and Toskala, Elina M and Rosen, Marc R and Nyquist, Gurston G and Rabinowitz, Mindy R},
title = {Sleep Subdomain of the Sinonasal Outcome Test as a Potential Screening Tool for Sleep Apnea in Chronic Rhinosinusitis},
journal = {The Laryngoscope},
year = {2023},
doi = {10.1002/lary.30730}
}
EUVIMED